Myriad Genetics, Inc.

Historical 13F Holders

Symbol
MYGN
CUSIP
62855J104
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 62855J104 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock Portfolio Management LLC 13G/A 8.6% 10/27/2026
Event 9/30/2026
BlackRock, Inc. 13G/A 8.5% 4/7/2026
Event 3/31/2026
Integrated Core Strategies (US) LLC 13G/A
7.2% 2/11/2026
Event 12/31/2025
State Street Corp 13G 5.3% 8/7/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Barclays PLC 13G/A 4.2% 11/12/2025
Event 9/30/2025
Camber Capital Management LP 13G/A
3.4% 2/14/2025
Event 12/31/2024
Disciplined Growth Investors Inc /MN 13G/A 0.8% 8/14/2025
Event 6/30/2025
Glenview Capital Management, LLC 13G/A
0% 8/14/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026
Vestal Point Capital, LP 13G/A
0% 11/16/2026
Event 9/30/2026
Wellington Management Group LLP 13G/A
0% 8/12/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 176 86.9 M $375M
2026 Q2 200 89.0 M $508M
2026 Q1 206 213 M $520M
2025 Q4 223 92.2 M $568M
2025 Q3 223 88.5 M $640M
2025 Q2 224 90.5 M $480M
2025 Q1 230 93.9 M $833M
2024 Q4 222 92.5 M $1.27B
2024 Q3 246 90.7 M $2.48B
2024 Q2 224 92.3 M $2.26B
2024 Q1 186 93.8 M $2.00B
2023 Q4 194 89.9 M $1.72B
2023 Q3 186 82.7 M $1.33B
2023 Q2 188 81.2 M $1.88B
2023 Q1 190 82.2 M $1.91B
2022 Q4 196 80.6 M $1.17B
2022 Q3 193 81.5 M $1.55B
2022 Q2 203 80.0 M $1.46B
2022 Q1 207 78.9 M $1.99B
2021 Q4 199 78.3 M $2.16B
2021 Q3 216 79.3 M $2.56B
2021 Q2 204 75.5 M $2.31B
2021 Q1 198 73.9 M $2.25B
2020 Q4 190 75.1 M $1.49B
2020 Q3 194 73.4 M $958M
2020 Q2 199 73.0 M $828M
2020 Q1 193 73.8 M $1.06B
2019 Q4 232 79.1 M $2.15B
2019 Q3 226 77.8 M $2.23B
2019 Q2 240 77.1 M $2.14B
2019 Q1 266 78.8 M $2.62B
2018 Q4 266 76.5 M $2.22B
2018 Q3 290 75.7 M $3.48B
2018 Q2 261 73.6 M $2.75B
2018 Q1 264 75.3 M $2.22B
2017 Q4 254 74.7 M $2.56B
2017 Q3 226 75.3 M $2.72B
2017 Q2 245 82.2 M $2.12B
2017 Q1 239 83.8 M $1.61B
2016 Q4 226 80.7 M $1.35B
2016 Q3 227 82.7 M $1.70B
2016 Q2 256 81.5 M $2.50B
2016 Q1 234 81.9 M $3.07B
2015 Q4 234 89.7 M $3.87B
2015 Q3 236 91.2 M $3.42B
2015 Q2 236 92.9 M $3.16B
2015 Q1 254 93.2 M $3.49B
2014 Q4 277 95.2 M $3.43B
2014 Q3 280 96.8 M $3.94B
2014 Q2 290 102 M $4.18B
2014 Q1 288 109 M $3.95B